LimFlow
Entity

  • LimFlow

    Created in 2016
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    326 7,337

  • Activities

    biotech deeptech healthtech

  • Entity types

    Startup

  • Location

    95 Bis Bd Pereire, 75017 Paris, France

    Paris

    France

  • Employees

    Scale: 11-50

    Estimated: 29

  • SIREN

    820710267

  • Engaged corporates

    1
    1 0

  • Added in Motherbase

    3 years, 8 months ago
Description
  • Value proposition

    Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI)

    LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation.

    LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations and restore mobility for patients. This novel technology provides a new and minimally-invasive option for “no option” CLTI patients that may help them improve their lives and avoid amputation. For additional information, please visit www.limflow.com.


    Critical Limb Ischemia, Wound Healing, Amputation Free, Endovascular, Perfusion, Venous Arterialization, Desert Foot, Diabetic Foot, Rutherford 5, Rutherford 6, and CLI Fighter

  • Original language

    Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI)

    LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation.

    LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations and restore mobility for patients. This novel technology provides a new and minimally-invasive option for “no option” CLTI patients that may help them improve their lives and avoid amputation. For additional information, please visit www.limflow.com.

Corporate interactions BETA
Corporate TypeTweets Articles
Sofinnova Partners
Sofinnova Partners
Financial Services
Sofinnova Partners
Financial Services 		Not capitalistic
Partnership
Event

22 Jun 2020

10 Oct 2024



Similar entities
Last news
Show all articles
Social network dynamics